Report Detail

Pharma & Healthcare Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Research Report 2021

  • RnM4283727
  • |
  • 02 February, 2021
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)

Segment
Pharmaceuticals Industry
Food Industry
Cosmetics Industry
Other

By Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

By Company
Kazmira
CW Hemp/CW Botanicals
Freedom Leaf
Green Road
Medical Marijuana
Folium Biosciences
HempLife Today
Cannavest
Pharmahemp
ENDOCA
CBD American Shaman
NuLeaf Naturals
Select Oil
K.I.N.D. Concentrates
Canopy Growth Corporation
Aphria
Emblem Cannabis Oils
Whistler
The Lab
Absolute Terps


1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Overview

  • 1.1 Product Overview and Scope of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
  • 1.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment
    • 1.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate Comparison (2021-2027)
    • 1.2.2 Tetrahydrocannabinol (THC)
    • 1.2.3 Cannabidiol (CBD)
  • 1.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment
    • 1.3.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Comparison : (2021-2027)
    • 1.3.2 Pharmaceuticals Industry
    • 1.3.3 Food Industry
    • 1.3.4 Cosmetics Industry
    • 1.3.5 Other
  • 1.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Estimates and Forecasts
    • 1.4.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2016-2027
    • 1.4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2016-2027
    • 1.4.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Competition by Manufacturers

  • 2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Sites, Area Served, Product Type
  • 2.5 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Competitive Situation and Trends
    • 2.5.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Players Market Share by Revenue
    • 2.5.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Retrospective Market Scenario by Region

  • 3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
    • 3.3.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
    • 3.3.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
    • 3.3.3 Mexico
  • 3.4 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
    • 3.4.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
    • 3.4.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 UK
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region
    • 3.5.2 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Indonesia
    • 3.5.9 Thailand
    • 3.5.10 Malaysia
    • 3.5.11 Philippines
    • 3.5.12 Vietnam
  • 3.6 Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
    • 3.6.1 Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
    • 3.6.2 Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country
    • 3.6.3 Brazil
  • 3.7 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
    • 3.7.2 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 GCC Countries
    • 3.7.5 Egypt
    • 3.7.6 South Africa

4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Historic Market Analysis

  • 4.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share (2016-2021)
  • 4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share (2016-2021)
  • 4.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price (2016-2021)

5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Historic Market Analysis

  • 5.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share (2016-2021)
  • 5.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share (2016-2021)
  • 5.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price (2016-2021)

6 Key Companies Profiled

  • 6.1 Kazmira
    • 6.1.1 Kazmira Corporation Information
    • 6.1.2 Kazmira Description and Business Overview
    • 6.1.3 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Kazmira Product Portfolio
    • 6.1.5 Kazmira Recent Developments/Updates
  • 6.2 CW Hemp/CW Botanicals
    • 6.2.1 CW Hemp/CW Botanicals Corporation Information
    • 6.2.2 CW Hemp/CW Botanicals Description and Business Overview
    • 6.2.3 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 CW Hemp/CW Botanicals Product Portfolio
    • 6.2.5 CW Hemp/CW Botanicals Recent Developments/Updates
  • 6.3 Freedom Leaf
    • 6.3.1 Freedom Leaf Corporation Information
    • 6.3.2 Freedom Leaf Description and Business Overview
    • 6.3.3 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Freedom Leaf Product Portfolio
    • 6.3.5 Freedom Leaf Recent Developments/Updates
  • 6.4 Green Road
    • 6.4.1 Green Road Corporation Information
    • 6.4.2 Green Road Description and Business Overview
    • 6.4.3 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Green Road Product Portfolio
    • 6.4.5 Green Road Recent Developments/Updates
  • 6.5 Medical Marijuana
    • 6.5.1 Medical Marijuana Corporation Information
    • 6.5.2 Medical Marijuana Description and Business Overview
    • 6.5.3 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Medical Marijuana Product Portfolio
    • 6.5.5 Medical Marijuana Recent Developments/Updates
  • 6.6 Folium Biosciences
    • 6.6.1 Folium Biosciences Corporation Information
    • 6.6.2 Folium Biosciences Description and Business Overview
    • 6.6.3 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Folium Biosciences Product Portfolio
    • 6.6.5 Folium Biosciences Recent Developments/Updates
  • 6.7 HempLife Today
    • 6.6.1 HempLife Today Corporation Information
    • 6.6.2 HempLife Today Description and Business Overview
    • 6.6.3 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 HempLife Today Product Portfolio
    • 6.7.5 HempLife Today Recent Developments/Updates
  • 6.8 Cannavest
    • 6.8.1 Cannavest Corporation Information
    • 6.8.2 Cannavest Description and Business Overview
    • 6.8.3 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Cannavest Product Portfolio
    • 6.8.5 Cannavest Recent Developments/Updates
  • 6.9 Pharmahemp
    • 6.9.1 Pharmahemp Corporation Information
    • 6.9.2 Pharmahemp Description and Business Overview
    • 6.9.3 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Pharmahemp Product Portfolio
    • 6.9.5 Pharmahemp Recent Developments/Updates
  • 6.10 ENDOCA
    • 6.10.1 ENDOCA Corporation Information
    • 6.10.2 ENDOCA Description and Business Overview
    • 6.10.3 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 ENDOCA Product Portfolio
    • 6.10.5 ENDOCA Recent Developments/Updates
  • 6.11 CBD American Shaman
    • 6.11.1 CBD American Shaman Corporation Information
    • 6.11.2 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.11.3 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 CBD American Shaman Product Portfolio
    • 6.11.5 CBD American Shaman Recent Developments/Updates
  • 6.12 NuLeaf Naturals
    • 6.12.1 NuLeaf Naturals Corporation Information
    • 6.12.2 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.12.3 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 NuLeaf Naturals Product Portfolio
    • 6.12.5 NuLeaf Naturals Recent Developments/Updates
  • 6.13 Select Oil
    • 6.13.1 Select Oil Corporation Information
    • 6.13.2 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.13.3 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Select Oil Product Portfolio
    • 6.13.5 Select Oil Recent Developments/Updates
  • 6.14 K.I.N.D. Concentrates
    • 6.14.1 K.I.N.D. Concentrates Corporation Information
    • 6.14.2 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.14.3 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 K.I.N.D. Concentrates Product Portfolio
    • 6.14.5 K.I.N.D. Concentrates Recent Developments/Updates
  • 6.15 Canopy Growth Corporation
    • 6.15.1 Canopy Growth Corporation Corporation Information
    • 6.15.2 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.15.3 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Canopy Growth Corporation Product Portfolio
    • 6.15.5 Canopy Growth Corporation Recent Developments/Updates
  • 6.16 Aphria
    • 6.16.1 Aphria Corporation Information
    • 6.16.2 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.16.3 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Aphria Product Portfolio
    • 6.16.5 Aphria Recent Developments/Updates
  • 6.17 Emblem Cannabis Oils
    • 6.17.1 Emblem Cannabis Oils Corporation Information
    • 6.17.2 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.17.3 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Emblem Cannabis Oils Product Portfolio
    • 6.17.5 Emblem Cannabis Oils Recent Developments/Updates
  • 6.18 Whistler
    • 6.18.1 Whistler Corporation Information
    • 6.18.2 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.18.3 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Whistler Product Portfolio
    • 6.18.5 Whistler Recent Developments/Updates
  • 6.19 The Lab
    • 6.19.1 The Lab Corporation Information
    • 6.19.2 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.19.3 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 The Lab Product Portfolio
    • 6.19.5 The Lab Recent Developments/Updates
  • 6.20 Absolute Terps
    • 6.20.1 Absolute Terps Corporation Information
    • 6.20.2 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Description and Business Overview
    • 6.20.3 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Absolute Terps Product Portfolio
    • 6.20.5 Absolute Terps Recent Developments/Updates

7 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Cost Analysis

  • 7.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
  • 7.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors List
  • 8.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers

9 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Dynamics

  • 9.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends
  • 9.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Growth Drivers
  • 9.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Challenges
  • 9.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Restraints

10 Global Market Forecast

  • 10.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Estimates and Projections
    • 10.1.1 Global Forecasted Sales of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (2022-2027)
  • 10.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Estimates and Projections
    • 10.2.1 Global Forecasted Sales of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (2022-2027)
  • 10.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Tetrahydrocannabinol (THC) and Cannabidiol (CBD). Industry analysis & Market Report on Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is a syndicated market report, published as Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Research Report 2021. It is complete Research Study and Industry Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,317.10
    3,475.65
    4,634.20
    2,714.40
    4,071.60
    5,428.80
    456,402.00
    684,603.00
    912,804.00
    242,121.00
    363,181.50
    484,242.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report